Table 2.
Group (number of veterans dispensed medicine during follow-up) | Interacting drug(s): | Patients dispensed interacting drug pair (%) |
---|---|---|
Warfarin (n = 19 049) | NSAIDs | 1373 (7.2%) |
Anti-platelet medicines | 1124 (5.9%) | |
Miconazole (or other imidazoles) | 0 | |
Allopurinol (n = 11 981) | Mercaptopurine | 0 |
Azathioprine | 3 (0.0%) | |
Amiloride (n = 360) | Potassium salts | 10 (2.8%) |
ACE inhibitors | 3 (0.8%) | |
Tacrolimus | 0 | |
Amiodarone (n = 4875) | Thioridazine | 0 |
Quinidine | 0 | |
Chlorpromazine | 2 (0.0%) | |
Disopyramide | 0 | |
Haloperidol | 17 (0.3%) | |
Phenothiazines | 113 (2.3%) | |
Sotalol | 11 (0.2%) | |
Digoxin | 300 (6.2%) | |
Verapamil (n = 7705) | β-adrenoceptor blockers | 412 (5.3%) |
Cyclosporin (n = 32) | Orlistat | 0 |
Statins | 15 (46.9%) | |
Spironolactone (n = 3308) | Amiloride | 2 (0.1%) |
Potassium salts | 135 (4.1%) | |
ACE inhibitors | 61 (1.8%) | |
Lithium | 4 (0.1%) | |
Tacrolimus/sirolimus | 0 | |
Methotrexate (n = 783) | Aspirin | 88 (11.2%) |
NSAIDs | 188 (24.0%) | |
Sildenafil, tadalafil, vardenafil (n = 2563) | Nitrates | 22 (0.9%) |
Atenolol (n = 22 956) | Clonidine | 30 (0.1%) |
Carbamazepine (n = 1128) | Dextropropoxyphene | 8 (0.7%) |
Imipramine (n = 1086) | Clonidine | 0 |
Entacapone | 0 | |
Moclobemide | 3 (0.3%) | |
Itraconazole (n = 16) | Pimozide | 0 |
Simvastatin/atorvastatin | 5 (31.3%) | |
Tacrolimus/sirolimus | 0 | |
Quinidine | 0 | |
Lithium (n = 278) | Haloperidol | 2 (0.7%) |
ACE inhibitor or AIIRB | 49 (17.6%) | |
Furosemide | 12 (4.3%) | |
Hydrochlorothiazide | 0 | |
Phenothiazines | 9 (3.2%) | |
Tramadol (n = 6433) | Monoamine oxidase inhibitors | 0 |
Pravastatin (n = 12 827) | Gemfibrozil | 52 (0.4%) |
Triptans (n = 175) | Ergot alkaloids | 3 (1.7%) |
Monoamine oxidase inhibitors | 2 (1.1%) | |
Methysergide | 5 (2.9%) | |
SSRIs | 22 (12.6%) | |
Captopril (n = 22 956) | Potassium salts | 413 (1.8%) |
Diclofenac (n = 4881) | Heparin | 8 (0.2%) |
Digoxin (n = 8992) | Quinidine | 14 (0.2%) |
Fluoxetine (n = 2368) | Moclobemide | 0 |
Selegiline | 0 |